Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Jan;104(1):109-17.
doi: 10.1111/j.1360-0443.2008.02421.x.

Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients

Affiliations
Randomized Controlled Trial

Randomized controlled trial of a brief intervention for problematic prescription drug use in non-treatment-seeking patients

Anne Zahradnik et al. Addiction. 2009 Jan.

Abstract

Aims: Dependence on or problematic use of prescription drugs (PD) is estimated to be between 1 and 2% in the general population. In contrast, the proportion of substance-specific treatment in PD use disorders at 0.5% is comparatively low. With an estimated prevalence of 4.7%, PD-specific disorders are widespread in general hospitals compared to the general population. Brief intervention delivered in general hospitals might be useful to promote discontinuation or reduction of problematic prescription drug use.

Design: A randomized, controlled clinical trial.

Setting: Internal, surgical and gynaecological wards of a general and a university hospital.

Participants: One hundred and twenty-six patients fulfilling criteria for either regular use of PD (more than 60 days within the last 3 months) or dependence on or abuse of PD, respectively, were allocated randomly to two conditions.

Intervention: Subjects received two counselling sessions based on Motivational Interviewing plus an individualized written feedback (intervention group, IG) or a booklet on health behaviour (control group, CG).

Measurements: The outcome was measured as reduction (>25%) and discontinuation of PD intake in terms of defined daily dosages (DDD).

Findings: After 3 months, more participants in the IG reduced their DDD compared to the participants in the CG (51.8% versus 30%; chi(2) = 6.17; P = 0.017). In the IG 17.9%, in the CG 8.6% discontinued use of PD (chi(2) = 2.42; P = 0.17). Conclusions Brief intervention based on Motivational Interviewing is effective in reducing PD intake in non-treatment-seeking patients.

Trial registration: ClinicalTrials.gov NCT00514839.

PubMed Disclaimer

Publication types

Substances

Associated data